Key Takeaway
Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.
Published August 7, 2026 · Category: News
Overview
Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.
Details
(Image credit: Fred Tanneau)
Source
Originally published at www.npr.org.
Related Articles
Frequently Asked Questions
What is "Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'" about?+
Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.
Who reported this story?+
This story was reported by NPR News.